首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Jhep reports

缩写:

ISSN:N/A

e-ISSN:2589-5559

IF/分区:7.5/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1150
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Agrin Moeini,Philipp K Haber,Daniela Sia Agrin Moeini
Biliary tract cancers (BTCs) are aggressive epithelial malignancies that can arise at any point of the biliary tree. Albeit rare, their incidence and mortality rates have been rising steadily over the past 40 years, highlighting the need to...
Theresa H Wirtz,Philipp A Reuken,Christian Jansen et al. Theresa H Wirtz et al.
Background & aims: Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine and an important regulator of innate immune responses. We hypothesised that serum concentrations of MIF are associated with disea...
Jerome Boursier,Emmanuel A Tsochatzis Jerome Boursier
Among the large population of patients with non-alcoholic fatty liver disease (NAFLD), identifying those with advanced disease remains challenging. Many patients are diagnosed late, following the development of liver-related complications, ...
Robert S Brown Jr,Michio Imawari,Namiki Izumi et al. Robert S Brown Jr et al.
Background & aims: Despite limitations, platelet transfusion has been used to minimise bleeding risk in patients with thrombocytopaenia. Lusutrombopag is an oral, thrombopoietin receptor agonist approved for treatment of ...
Sergio Muñoz-Martínez,Victor Sapena,Alejandro Forner et al. Sergio Muñoz-Martínez et al.
Background & aims: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether t...
Noa Shafran,Assaf Issachar,Tzippy Shochat et al. Noa Shafran et al.
Background & aims: Abnormal liver tests are common in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but a possible direct role of the virus in liver injury and its association with ...
Guillaume Grzych,Oscar Chávez-Talavera,Amandine Descat et al. Guillaume Grzych et al.
Background & aims: Plasma bile acids (BAs) have been extensively studied as pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from clinical studies are often complicated by the associatio...
Tsz Tung Kwong,Chi Hang Wong,Jing Ying Zhou et al. Tsz Tung Kwong et al.
Background & aims: Immune checkpoint blockade (ICB) has been approved for treatment of hepatocellular carcinoma (HCC). However, many patients with advanced HCC are non-responders to ICB monotherapy. Cytotoxic chemotherapy...
Jeffrey C To,Amy P Chiu,Barbara R Tschida et al. Jeffrey C To et al.
Background & aims: Zinc finger and BTB domain containing 20 (ZBTB20) has been implicated as a potential oncogene in liver cancer. However, knockout studies have shown it to be a transcriptional repressor of the alpha-foet...
Valeska Bidault-Jourdainne,Grégory Merlen,Mathilde Glénisson et al. Valeska Bidault-Jourdainne et al.
Background & aims: As the composition of the bile acid (BA) pool has a major impact on liver pathophysiology, we studied its regulation by the BA receptor Takeda G protein coupled receptor (TGR5), which promotes hepatopro...